Socioeconomic status and use of obesogenic and anti-obesity medications in the United States: A population-based study

BACKGROUND: The Endocrine Society Clinical Practice Guidelines recommend the avoidance of medications that may cause weight gain (i.e., obesogenic medications) in individuals with overweight or obesity. Obesity disproportionately affects people with lower socioeconomic status (SES); however, it is u...

Descripción completa

Detalles Bibliográficos
Autores principales: Lyu, Beini, Chang, Alex R., Inker, Lesley A., Selvin, Elizabeth, Grams, Morgan E., Shin, Jung-Im
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348594/
https://www.ncbi.nlm.nih.gov/pubmed/35928911
http://dx.doi.org/10.1016/j.lana.2022.100249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348594/
https://www.ncbi.nlm.nih.gov/pubmed/35928911
http://dx.doi.org/10.1016/j.lana.2022.100249

Ejemplares similares